Clinical Trials

Doctors Poulos and Fisher, and the entire team of dermatologists at Kingsway Dermatology strongly believe that being at the forefront of medical research is a vital part of their practice.

In keeping with our mission to provide outstanding patient care, Kingsway Clinical Research was established in 2014, as a division of Kingsway Dermatology, that specializes in clinical trials in collaboration with Probity Medical Research.

Our goal is to help bring safe and effective cutting edge treatments to our patients. This work allows our patients access to medications, sometimes years ahead of the commercial launch. It also allows our patients access to medications that may not be covered under insurance programs.

Kingsway Dermatology Front Desk
Short hair woman reading

Why choose Kingsway Clinical Research?

  • Trusted reputation of our team of experienced, Board certified Dermatologists, with experience in clinical trials
  • Our research centre is interconnected with a busy dermatology clinic with a large and non-transient patient population
  • Conveniently located – right across the Islington subway station, 10 km from St. Joseph’s Hospital, and 12 km from Toronto Pearson International Airport
  • Presence of investigators while study patients are scheduled
  • Assurance of strictest patient confidentiality, privacy and professionalism

Why volunteer for clinical trials?

Check Icon

Access to alternative treatments and novel drugs

Check Icon

Taking an active role in your health care

Check Icon

Comprehensive medical care from overseeing physician and dedicated clinical trials staff

Check Icon

Opportunity to contribute to advancements in medical research

Check Icon

No cost on your part and compensation for travel associated with the study is available

Dr. Elena Poulos Dermatologist at Kingsway Dermatology

Meet Dr. Elena Poulos

Dr. Elena Poulos completed her Bachelor of Science degree at the University of Toronto, and graduated from medical school at the University of Ottawa. She went on to complete her dermatology residency…

Dr. Marine Fisher Cosmetic Dermatologist in Ontario

Meet Dr. Marnie e. Fisher

Dr. Fisher completed her B.Sc.H. at Queen’s University, and her M.Sc. in Photodynamic Therapy and Photomedicine in the Department of Pathology at Queen’s. After graduating from the University of Ottawa Medical School…

Kingsway dermatology logo icon

Current and Upcoming Trials

Join our clinical trials now for free, early access to the latest dermatology treatments! If you’re interested in helping our trusted team, contact our clinical trials coordinator at (416) 231-0100, extension 212, or email cl**********************@ki*****************.com.

ATOPIC DERMATITIS

  • Clinical study details to follow. Study medication and study-related assessments will be provided at no cost. Reimbursement for reasonable study-related expenses will also be provided.

Ongoing Trials (Enrollment is closed)

ATOPIC DERMATITIS

  • Open label, long term extension trial to evaluate the efficacy and safety of Tralokinumab in subjects with atopic dermatitis
  • A Phase 3 Randomized, Placebo-Controlled, Double-blind Study to Evaluate Upadacitinib in Adolescent and Adult Subjects with Moderate to Severe Atopic Dermatitis
  • A phase 3 long-term extension study investigating the efficacy and safety of Abrocitinib, Administered to subjects aged 12 years and older with moderate to severe atopic dermatitis
  • A phase 3 extension trial of DELTA 1 and DELTA 2 to evaluate the long-term safety of a twice-daily treatment with delgocitinib cream 20 mg/g as needed for up to 36 weeks in adult subjects with chronic hand eczema (DELTA 3)

PSORIASIS

  • Phase 3 open label study to assess the safety and efficacy of Risankizumab for maintenance in moderate to severe plaque psoriasis
  • A Multicenter, Randomized, Double-blind Study Evaluating the Pharmacokinetics, Efficacy,Safety, and Immunogenicity of Multiple Switches Between Humira®(adalimumab [US]) and ABP 501 Compared With Continued Use of Adalimumab in Subjects With Moderate to Severe Plaque Psoriasis

VITILIGO

  • A Double-blind, Vehicle-controlled Randomized Withdrawal and Treatment Extension Study to Assess the Long-Term Efficacy and Safety of Ruxolitinib Cream in Participants with Vitiligo
  • A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Efficacy and Safety of INCB054707 Followed by an Extension Period in Participants With Vitiligo

ALOPECIA AREATA

  • A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients with Moderate to Severe Alopecia Areata

COMPLETED TRIALS

ACNE

  • A safety and efficacy study to compare dapsone dermal gel with vehicle control in patients with acne vulgaris

ATOPIC DERMATITIS

  • Double blind, vehicle-controlled Phase IIb study to assess the safety and efficacy of topically applied DS107 cream in mild to moderate atopic dermatitis
  • Phase 3 confirmatory study investigating efficacy and safety of dupilumab monotherapy in adults with moderate to severe atopic dermatitis
  • Phase 3 double blind, placebo-controlled study investigating the efficacy and safety of multiple Dupilumab dose regimens for maintaining response in patients with atopic dermatitis
  • Open label study of Dupilumab in patients with atopic dermatitis
  • Tralokinumab monotherapy for adults with moderate to severe atopic dermatitis
  • Double blind, placebo-controlled study to evaluate the efficacy and safety of Barictinib in adults with moderate to severe atopic dermatitis
  • Open label, phase 3 study to evaluate efficacy and safety of Bariticinib in adults with moderate to severe atopic dermatitis

PSORIASIS

  • Canadian Humira post-marketing observational epidemiological study assessing effectiveness in psoriasis
  • Phase 3 study to evaluate the efficacy and safety of Brodalumab compared with placebo and Ustekinumab in subjects with moderate to severe plaque psoriasis
  • Open label study to assess the safety of Etanercept in subjects with plaque psoriasis
  • Risankizumab versus placebo in patients with moderate to severe plaque psoriasis
  • Double blind study of Secukinumab to demonstrate efficacy compared to Ustekinumab in subjects with moderate to severe plaque psoriasis
  • Double blind, active-control study to compare efficacy and safety of CHS-1420 versus Humira in subjects with chronic plaque psoriasis
  • Double blind study assessing short and long term efficacy, safety and tolerability of Secukinumab in subjects of body weight 90 kg or higher with moderate to severe plaque psoriasis
  • A Phase 3 Efficacy and safety study of Taparinof for the treatment of plaque psoriasis in adults
  • A Phase 3, Multicenter, Randomized, Double Blind Study Evaluating the Efficacy and Safety of ABP654 Compared with Ustekinumab in Subjects with Moderate to Severe Plaque Psoriasis

VITILIGO

  • Phase 3 Double-blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib cream Followed by an Extension period in Participants with Vitiligo

Patient testimonials

Beth MachirBeth Machir
02:25 26 Nov 22
Dr. Fisher has been my dermatologist since I had cancer 12 years ago. What knowledge and what kindness! She explains everything in details, using at times analogies and drawings to educate patients. This is going beyond the call of duty to help patients understand their conditions. She is a great professor with considerable expertise in her field. I highly recommend her as a dermatologist and as a human being.
Paula KastonPaula Kaston
14:31 17 Nov 22
The Kingsway Dermatology team are excellent and very professional. I have been going here for some years now to address all of my skin care issues. I am especially pleased with the results from Halo treatments with Katie. All the staff and both medical and cosmetic are exceptional. Highly recommended.
Kaitlyn SchullerKaitlyn Schuller
19:08 13 Oct 22
My experience at Kingsway has been nothing but short of amazing. The clinic itself is extremely clean and all the staff members are very professional and helpful. Emily has been treating my skin since April. I always look forward to seeing her as she is very knowledgeable, kind and gentle with my treatments. She always ensures that I am comfortable and always checks to see if I am happy with my current results. I feel so confident coming here that my skin goals will be achieved with the understanding and caring that Emily always provides!
Jessica KainthJessica Kainth
13:33 17 Aug 22
I went in to Kingsway Dermatology for a consultation and I was so happy with the appointment. Nadia was my consultant and she was so helpful and positive. She answered all my questions before I even asked them and she really listened to all my concerns. I felt like she really just got it. Probably one of the best consultations I've had. I really recommend talking to her for your consultation.The clinic is very clean and the staff was very friendly. The location is very easy to get to. There's also paid parking above ground and underground.
Susannah MargisonSusannah Margison
02:04 24 Jun 22
I cannot say enough good things about Kingsway Dermatology and Dr Ruppel. The results I get from my treatments with Dr R are second-to-none and she always has a way of making me feel incredibly at ease and comfortable. She’s a wonderful clinician and has an absolutely lovely bedside manner. She will go the extra mile to make sure you don’t feel rushed, that you feel welcome and that you’re more than just a number. I would recommend her twenty times over and I’m just thrilled that I found such a caring knowledgeable dermatologist. The clinic staff are also lovely, friendly and welcoming. Highly, highly recommend.
js_loader

Cosmetic Questions? Contact Our Office